Literature DB >> 12071671

Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice.

John E Morley1, Susan A Farr, James F Flood.   

Abstract

SAMP8 (senescence-accelerated mouse, P8 strain) mice overproduce amyloid precursor protein and beta-amyloid and have learning and memory deficits. Preliminary data have indicated that overproduction of beta-amyloid plays a role in the pathogenesis of acquisition and retention deficits in SAMP8 mice. In the studies reported here, the authors examined the effects of polyclonal and monoclonal antibodies to beta-amyloid on acquisition and retention in an aversive T-maze testing paradigm when injected intracerebroventricularly (ICV) into 12-month SAMP8/TaJF mice. Both the polyclonal and monoclonal antibodies improved acquisition and retention when injected ICV 1 to 14 days prior to acquisition testing. Injection of all three antibodies intrahippocampally immediately following training improved retention on the T-maze when mice were tested 7 days later. The authors next studied the effect of monoclonal beta-amyloid antibody injected 48 h prior to training on the effect on retention in the T-maze of drugs modulating classical neurotransmitters. Arecoline and glutamate were injected directly into the hippocampus, and ketanserin, methiothepen, bicuculline, and OH-saclofen were injected into the septum. Previously, the authors have found that the doses of these drugs required to improve retention are markedly altered in 12-month SAMP8/TkJF mice compared to 4-month P8 mice. In these studies, it was demonstrated that antibody to beta-amyloid resulted in these drugs improving retention at doses that improved memory in 4-month SAMP8/TaJF mice. Based on these findings, we conclude that beta-amyloid overproduction is at least in part responsible for the acquisition and memory deficits in 12-month-old SAMP8/TaJF mice. Antibody to beta-amyloid restores the retention response to neurotransmitter manipulation to that seen in 4-month-old mice. beta-amyloid appears to play a key role in the loss of acquisition and retention seen in SAMP8/TaJF mice. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071671     DOI: 10.1006/nlme.2001.4047

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  19 in total

1.  Early postnatal sound exposure induces lasting neuronal changes in the inferior colliculus of senescence accelerated mice (SAMP8): a morphometric study on GABAergic neurons and NMDA expression.

Authors:  Dietrich Ernst Lorke; Lai Yung Wong; Helen W L Lai; Paul W F Poon; Aiqun Zhang; Wood Yee Chan; David Tai Wai Yew
Journal:  Cell Mol Neurobiol       Date:  2003-04       Impact factor: 5.046

2.  Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.

Authors:  Naoko Nonaka; Susan A Farr; Tomoya Nakamachi; John E Morley; Masanori Nakamura; Seiji Shioda; William A Banks
Journal:  Peptides       Date:  2012-06-09       Impact factor: 3.750

Review 3.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice.

Authors:  Karin E Sandoval; Susan A Farr; William A Banks; Michael L Niehoff; John E Morley; Albert M Crider; Ken A Witt
Journal:  Eur J Pharmacol       Date:  2010-12-24       Impact factor: 4.432

5.  Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).

Authors:  D Porquet; P Andrés-Benito; C Griñán-Ferré; A Camins; I Ferrer; A M Canudas; J Del Valle; Mercè Pallàs
Journal:  Age (Dordr)       Date:  2015-02-08

Review 6.  Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

Authors:  William A Banks
Journal:  Adv Drug Deliv Rev       Date:  2011-12-17       Impact factor: 15.470

7.  Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice.

Authors:  William A Banks; John E Morley; Susan A Farr; Tulin O Price; Nuran Ercal; Irving Vidaurre; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

Review 8.  Proteomics in animal models of Alzheimer's and Parkinson's diseases.

Authors:  Renã A Sowell; Joshua B Owen; D Allan Butterfield
Journal:  Ageing Res Rev       Date:  2008-07-18       Impact factor: 10.895

9.  SAMP8 mice have altered hippocampal gene expression in long term potentiation, phosphatidylinositol signaling, and endocytosis pathways.

Authors:  Harvey J Armbrecht; Akbar M Siddiqui; Michael Green; Susan A Farr; Vijaya B Kumar; William A Banks; Ping Patrick; Gul N Shah; John E Morley
Journal:  Neurobiol Aging       Date:  2013-08-19       Impact factor: 4.673

10.  Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8.

Authors:  David Porquet; Gemma Casadesús; Sergi Bayod; Alberto Vicente; Anna M Canudas; Jordi Vilaplana; Carme Pelegrí; Coral Sanfeliu; Antoni Camins; Mercè Pallàs; Jaume del Valle
Journal:  Age (Dordr)       Date:  2012-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.